Fusion Pharmaceuticals Inc. Long-term Debt, Gross
Fusion Pharmaceuticals Inc. had Long-term Debt, Gross of $50.00 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentCarryingAmount · last filed 2024-05-07
- 2024-03-31: Long-term Debt, Gross $50.00M.
- 2023-12-31: Long-term Debt, Gross $35.00M.
- 2023-09-30: Long-term Debt, Gross $35.00M.
- 2023-06-30: Long-term Debt, Gross $35.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2024-03-31 | $50.00M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $35.00M 10-K · filed 2024-03-20 |
| 2023-09-30 | $35.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $35.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $35.00M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $35.00M 10-K · filed 2024-03-20 |
| 2022-09-30 | $35.00M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $10.00M 10-Q · filed 2022-08-09 |